NSCH Published 30Day FRN_87 FR 11409

NSCH Published 30Day FRN_87 FR 11409.pdf

National Survey of Children's Health

NSCH Published 30Day FRN_87 FR 11409

OMB: 0607-0990

Document [pdf]
Download: pdf | pdf
jspears on DSK121TN23PROD with NOTICES1

Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices
Data will be collected in two distinct
phases. In Phase 1, a pilot, consisting of
approximately ten percent of the final
panel (1,700 people) will be recruited
and surveyed as a proof-of-concept to
refine methods. In Phase 2, the full
panel will be recruited and surveyed
using methodology refined during Phase
1. This 30-day notice seeks clearance for
the Phase 1 Pilot. A future 30-day notice
will outline specific plans for Phase 2.
Affected Public: Individuals or
households.
Frequency: Twice a year.
Respondent’s Obligation: Voluntary.
Legal Authority: The Pilot is being
developed under a cooperative
agreement awarded by the Census
Bureau pursuant to the Consolidated
Appropriations Act of 2021, Public Law
116–260, Section 110. Data collection
from the Panel for Census Bureau
sponsored surveys is authorized by Title
13, Sections, 131, 141, 161, 181, 182,
193, and 301. Data collection from the
Panel for surveys sponsored by other
agencies is authorized by 13 U.S.C. 8(b),
where the Census Bureau is the
collection agent, 44 U.S. Code 3509,
where OMB can direct data collection,
and the various U.S. Code titles that
authorize those agencies to collect
information, including but not limited
to Title 49, Section 329 for Bureau of
Transportation Statistics collections,
and the Education Sciences Reform Act
of 2002 (ESRA 2002, 20 U.S.C. 9543) for
National Center for Education Statistics
surveys.
The confidentiality of information
collected on topical surveys in this
panel is assured by CIPSEA, Title 13
United States Code, or other applicable
titles which authorize the collection of
information.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view the
Department of Commerce collections
currently under review by OMB.
Written comments and
recommendations for the proposed
information collection should be
submitted within 30 days of the
publication of this notice on the
following website www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function and
entering the title of the collection.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2022–04222 Filed 2–28–22; 8:45 am]
BILLING CODE 3510–07–P

VerDate Sep<11>2014

19:01 Feb 28, 2022

Jkt 256001

DEPARTMENT OF COMMERCE
Census Bureau
Agency Information Collection
Activities; Submission to the Office of
Management and Budget (OMB) for
Review and Approval; Comment
Request; National Survey of Children’s
Health
The Department of Commerce will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995, on or after the date of publication
of this notice. We invite the general
public and other Federal agencies to
comment on proposed, and continuing
information collections, which helps us
assess the impact of our information
collection requirements and minimize
the public’s reporting burden. Public
comments were previously requested
via the Federal Register on November 9,
2021 during a 60-day comment period.
This notice allows for an additional 30
days for public comments.
Agency: U.S. Census Bureau.
Title: National Survey of Children’s
Health.
OMB Control Number: 0607–0990.
Form Number(s): NSCH–S1 (English
Screener), NSCH–T1 (English Topical
for 0- to 5-year-old children), NSCH–T2
(English Topical for 6- to 11-year-old
children), NSCH–T3 (English Topical
for 12- to 17-year-old children), NSCH–
S–S1 (Spanish Screener), NSCH–S–T1
(Spanish Topical for 0- to 5-year-old
children), NSCH–S–T2 (Spanish Topical
for 6- to 11-year-old children), and
NSCH–S–T3 (Spanish Topical for 12- to
17-year-old children).
Type of Request: Regular submission,
Request for a Revision of a Currently
Approved Collection.
Number of Respondents: 71,380 for
the screener only and 60,504 for the
combined screener and topical, for a
total of 131,884 respondents.
Average Hours per Response: 5
minutes per screener response and 35–
36 minutes per topical response, which
in total is approximately 40–41 minutes
for households with eligible children.
Burden Hours: 46,587.
Needs and Uses: The National Survey
of Children’s Health (NSCH) enables the
Maternal and Child Health Bureau
(MCHB) of the Health Resources and
Services Administration (HRSA) of the
U.S. Department of Health and Human
Services (HHS) along with supplemental
sponsoring agencies, states, and other
data users to produce national and statebased estimates on the health and well-

PO 00000

Frm 00015

Fmt 4703

Sfmt 4703

11409

being of children, their families, and
their communities as well as estimates
of the prevalence and impact of children
with special health care needs.
Data will be collected using one of
two modes. The first mode is a web
instrument (Centurion) survey that
contains the screener and topical
instruments. The web instrument first
will take the respondent through the
screener questions. If the household
screens into the study, the respondent
will be taken directly into one of the
three age-based topical sets of questions.
The second mode is a mailout/mailback
of a self-administered paper-and-pencil
interviewing (PAPI) screener instrument
followed by a separate mailout/mailback
of a PAPI age-based topical instrument.
The National Survey of Children’s
Health (NSCH) is a large-scale (sample
size is up to 360,000 addresses) national
survey with approximately 200,000
addresses included in the base
production survey and approximately
160,000 addresses included as part of
eleven separate age-based, state-based,
or region-based oversamples. The 2022
NSCH will include a topical incentive
test. Prior cycles of the survey have
included a $5 unconditional cash
incentive with the initial mailing of the
paper topical questionnaire. The
incentive has proven to be a costeffective intervention for increasing
survey response and reducing
nonresponse bias. The 2022 NSCH will
continue to test a $10 cash incentive,
with a focus on lower responding
households.
As in prior cycles of the NSCH, there
remain two key, non-experimental
design elements. The first additional
non-experimental design element is a $5
screener cash incentive mailed to 90%
of sampled addresses; the remaining
10% (the control) will receive no
incentive to monitor the effectiveness of
the cash incentive. This incentive is
designed to increase response and
reduce nonresponse bias. The incentive
amount was chosen based on the results
of the 2021 NSCH as well as funding
availability. The second additional nonexperimental design element is a data
collection procedure based on the block
group-level paper-only response
probability used to identify households
(30% of the sample) that would be more
likely to respond by paper and send
them a paper questionnaire in the initial
mailing.
Affected Public: Individuals or
households.
Frequency: The 2022 collection is the
seventh administration of the NSCH. It
is an annual survey, with a new sample
drawn for each administration.
Respondent’s Obligation: Voluntary.

E:\FR\FM\01MRN1.SGM

01MRN1

11410

Federal Register / Vol. 87, No. 40 / Tuesday, March 1, 2022 / Notices

Legal Authority:
Census Authority: Title 13, United
States Code (U.S.C.), Section 8(b) (13
U.S.C. 8(b)).
HRSA MCHB Authority: Section
501(a)(2) of the Social Security Act (42
U.S.C. 701).
United States Department of
Agriculture Authority: Agriculture
Improvement Act of 2018, Public Law
115–334.
United States Department of Health
and Human Services’ Centers for
Disease Control and Prevention,
National Center on Birth Defects and
Developmental Disabilities Authority:
Public Health Service Act, Section 301,
42 U.S.C. 241.
United States Department of Health
and Human Services’ Centers for
Disease Control and Prevention,
National Center for Chronic Disease
Prevention and Health Promotion
Authority: Sections 301(a), 307, and
399G of the Public Health Service [42
U.S.C. 241(a), 242l, and 280e–11], as
amended.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view the
Department of Commerce collections
currently under review by OMB.
Written comments and
recommendations for the proposed
information collection should be
submitted within 30 days of the
publication of this notice on the
following website www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function and
entering either the title of the collection
or the OMB Control Number 0607–0990.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2022–04224 Filed 2–28–22; 8:45 am]
BILLING CODE 3510–07–P

DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board

jspears on DSK121TN23PROD with NOTICES1

[B–6–2022]

Foreign-Trade Zone (FTZ) 43—Battle
Creek, Michigan; Notification of
Proposed Production Activity; Pfizer,
Inc. (Nirmatrelvir Active
Pharmaceutical Ingredient (API) for
COVID–19 Treatment); Kalamazoo,
Michigan

activity to the FTZ Board for its facility
Kalamazoo, Michigan. The notification
conforming to the requirements of the
Board’s regulations (15 CFR 400.22) was
received on February 22, 2022.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status materials/
components and specific finished
product described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz. The proposed finished product and
materials/components would be added
to the production authority that the
Board previously approved for the
operation, as reflected on the Board’s
website.
The proposed finished product is
Nirmatrelvir API (duty rate, 6.5%).
The proposed foreign-status materials
and components include Registered
Starter Chemical PF-04349713-01,
Registered Starter Chemical PF07321787, Registered Starter Chemical
PF-07328614-01, 2-Hydroxypyridine-Noxide (HOPO), and
Dimethylaminopropylethyl
carbodiimide hydrochloride (EDC HCI)
(duty rates are 3.7% or 6.5%). The
request indicates that certain materials/
components are subject to duties under
Section 301 of the Trade Act of 1974
(Section 301), depending on the country
of origin. The applicable Section 301
decisions require subject merchandise
to be admitted to FTZs in privileged
foreign status (19 CFR 146.41).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: [email protected]. The
closing period for their receipt is April
11, 2022.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact Diane
Finver at [email protected].
Dated: February 23, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022–04225 Filed 2–28–22; 8:45 am]
BILLING CODE 3510–DS–P

Pfizer, Inc. (Pfizer) submitted a
notification of proposed production

VerDate Sep<11>2014

19:01 Feb 28, 2022

Jkt 256001

PO 00000

Frm 00016

Fmt 4703

Sfmt 4703

DEPARTMENT OF COMMERCE
International Trade Administration
[A–580–836]

Certain Cut-to-Length Carbon-Quality
Steel Plate Products From the
Republic of Korea: Preliminary Results
of Antidumping Duty Administrative
Review; 2020–2021
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) preliminarily finds that
producers/exporters subject to this
administrative review made sales of
subject merchandise at less than normal
value during the period of review (POR),
February 1, 2020, through January 31,
2021. We invite interested parties to
comment on these preliminary results of
review.
DATES: Applicable March 1, 2022.
FOR FURTHER INFORMATION CONTACT:
Andre Gziryan, AD/CVD Operations,
Office I, Enforcement and Compliance,
International Trade Administration,
U.S. Department of Commerce, 1401
Constitution Avenue NW, Washington,
DC 20230; telephone: (202) 482–2201.
SUPPLEMENTARY INFORMATION:
AGENCY:

Background
On February 10, 2000, Commerce
published in the Federal Register an
antidumping duty order on certain cutto-length carbon-quality steel plate
products (CTL plate) from the Republic
of Korea (Korea).1 On February 2, 2021,
we published in the Federal Register a
notice of opportunity to request an
administrative review of the Order.2 On
April 1, 2021, based on timely requests
for an administrative review Commerce
initiated the administrative review of
four companies.3
On October 14, 2021, Commerce
extended the time limit for issuing the
preliminary results of this review by 117
days, to no later than February 25,
2022.4 For a complete description of the
1 See Notice of Amendment of Final
Determinations of Sales at Less Than Fair Value
and Antidumping Duty Orders: Certain Cut-ToLength Carbon-Quality Steel Plate Products from
France, India, Indonesia, Italy, Japan and the
Republic of Korea, 65 FR 6585 (February 10, 2000)
(Order).
2 See Antidumping or Countervailing Duty Order,
Finding, or Suspended Investigation; Opportunity
to Request Administrative Review, 86 FR 7855
(February 2, 2021).
3 See Initiation of Antidumping and
Countervailing Duty Administrative Reviews, 86 FR
17124 (April 1, 2021) (Initiation Notice).
4 See Memorandum, ‘‘Certain Cut-to-Length
Carbon-Quality Steel Plate Products from the
Republic of Korea: Extension of Deadline for

E:\FR\FM\01MRN1.SGM

01MRN1


File Typeapplication/pdf
File Modified2022-03-01
File Created2022-03-01

© 2024 OMB.report | Privacy Policy